Announcing Jennifer Fried as CEO and Co-Founder

Flow Medical, a physician-founded developer of a novel thrombolytic catheter to treat pulmonary embolism, today announced that Jennifer Fried has been named as Chief Executive Officer and Co-Founder.

Fried has spent her career as an early-stage healthcare investor, founder and operator. Most recently, she served as CEO and Co-Founder of Explorer Surgical, a surgical software platform founded based on research at The University of Chicago Medical Center. She led the company from ideation through commercialization and successfully exited the business in 2021 to GHX. Previously, Fried was a venture capitalist focused on early-stage medtech and healthtech, and a consultant at Bain & Company.

“Jennifer completes our team,” said Dr. Jonathan Paul, Flow Medical’s Chief Scientific Officer. “Jennifer’s experience building early-stage healthcare companies as both an investor and operator will enable us to rapidly accelerate our efforts to bring our novel device to market to serve our patients.” Dr. Osman Ahmed, Flow’s Chief Medical Officer adds, “We are thrilled to partner with an experienced CEO with a successful track record partnering with physicians to bring new products to market. Jennifer began advising our team in February and has already made a tremendous amount of impact on the business - we are beyond excited to officially have her on board as CEO.”

“I am honored to be joining the Flow Medical team,” said Jennifer Fried. “Flow Medical’s technology solves one of the most pressing clinical questions in PE treatment and has the opportunity to help millions of patients annually. What JP and Os have invented is truly unique. They refused to accept the status quo for their VTE patients and took their combined experience as physicians and researchers to build a device that can personalize treatment for each patient. The market is primed for a new device in this space and I am delighted to lead the charge.”

As co-founder and CEO of Explorer Surgical, Jennifer successfully raised more than $10M in private capital and NSF grant funding, on-boarded several dozen major medical device customers, and led the product to be used globally across five continents. The company and Jennifer received numerous industry accolades, including being named as one of Top 50 Healthcare Technology CEOs of 2021.

Jennifer received a BA with Honors in Mathematical Methods in the Social Sciences and Economics from Northwestern University and an MBA with Honors from The University of Chicago Booth School of Business.